Asparagine–tRNA ligase, cytoplasmic, also called asparaginyl-tRNA synthetase 1, is an enzyme that in humans is encoded by the NARS1gene. NARS1 functions to attach the amino acid asparagine to its corresponding transfer RNA (tRNAAsn), which is important for incorporating asparagine into proteins during protein synthesis.
Function
The NARS1 protein is an example of an aminoacyl-tRNA synthetase, which are a class of enzymes that charge tRNAs with their cognate amino acids, in this case attaching asparagine to tRNAAsn to form the aminoacyl-tRNA, L-asparaginyl-tRNAAsn. This enzyme typically binds with another copy of itself to form a homodimer, and does not appear to be part of the multi-synthetase complex.
In humans, NARS1 is particularly important in the development of the cerebral cortex, where it is required for the proliferation of radial glial cells. Outside of its core role in protein synthesis, it can also act as a signaling molecule which is able to induce the migration of CCR3-expressing cells.
Family
Cytoplasmic asparaginyl-tRNA synthetase belongs to the class II-b family of tRNA synthetases along with Aspartyl-tRNA synthetase and Lysyl-tRNA synthetase II. The N-terminal domain represents the signature sequence for the eukaryotic asparaginyl-tRNA synthetases.
Medical significance
Certain heterozygous mutations in NARS1 are associated with a brain development and neurological disorder called neurodevelopmental disorder with microcephaly, impaired language, epilepsy, and gait abnormalities (NEDMILEG). More diverse pathogenic homozygous and compound heterozygous are also associated with a syndrome with many similar symptoms called neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities (NEDMILG)